Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Sawai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sawai's Japan sales performance.

China: AstraZeneca’s new engine for growth and innovation

China: AstraZeneca’s new engine for growth and innovation

To conclude, there is no doubt that the US, Europe and Japan remain the lead launch markets.

Bayer roll-out of haemophilia drug Jivi gathers pace

Bayer roll-out of haemophilia drug Jivi gathers pace Bayer roll-out of haemophilia drug Jivi gathers pace. Japan’s MHLW is next to approve the drug. ... As in the US, the drug is approved in Japan for on-demand treatment and bleeding management during surgeries.

Encouraging data for Roche flu drug ahead of FDA decision

Encouraging data for Roche flu drug ahead of FDA decision Discovered and developed by Shionogi, the drug is already approved in Japan and marketed as Xofluza, with Roche holding the marketing rights  outside Japan and Taiwan.

GSK to reverse ‘no KOL’ policy, admitting it has hit marketing

GSK to reverse ‘no KOL’ policy, admitting it has hit marketing The changes will be applied first to select products in the US and Japan from this month, then rolled out to Europe, North America and Asia from 2019 if it proves

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics